As enterprise security leaders demand cyber-hardened infrastructure, lower deployment costs, and greater scalability, ...

Drug companies have quietly stepped back from development programs in long COVID and related conditions, leaving patients with few options. Credit: Madeline Monroe/C&EN/Shutterstock Drug manufacturers ...